Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AX-158 by Artax Biopharma for Autoimmune Disorders: Likelihood of Approval
AX-158 is under clinical development by Artax Biopharma and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...
Data Insights
AX-158 by Artax Biopharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
AX-158 is under clinical development by Artax Biopharma and currently in Phase I for Atopic Dermatitis (Atopic Eczema). According to...